Literature DB >> 14872021

Further evidence of dementia in SPG4-linked autosomal dominant hereditary spastic paraplegia.

Paul McMonagle1, Paula Byrne, Michael Hutchinson.   

Abstract

OBJECTIVE: To investigate the progression of cognitive impairment and its behavioral aspects in patients with SPG4-linked autosomal dominant hereditary spastic paraplegia (SPG4-ADHSP).
METHODS: Sixteen patients, 45 years or older, from five families with SPG4-ADHSP were prospectively assessed. Eleven of these, from three families, were followed and 10 had two cognitive examinations using the Cambridge Cognitive Assessment (CAMCOG) 2.9 years apart. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), the Neuropsychiatric Inventory (NPI), and the Nurses' Observation Scale for Geriatric Patients (NOSGER) were completed by close relatives of the 11 patients at the second assessment. Eleven matched control subjects had CAMCOG examinations 3.1 years apart.
RESULTS: The mean CAMCOG score at the initial assessment was lower for the 10 HSP patients (73.5/107) than for 10 control subjects (91.7/107, p = 0.005). After 2.9 years, the HSP patients experienced a fall in the mean CAMCOG by 9.1 points to 64.4/107 (p = 0.008). The mean CAMCOG score for the control subjects (90.8/107) fell by only 0.9 points after 3.1 years (p = 0.36). The CAMCOG scores of two HSP patients moved from the mild (60 to 80) into the moderate dementia category (35 to 59) and in three other patients into the mild dementia range from borderline normal scores (81 to 85). IQCODE scores were abnormal in 9/11 HSP patients and 1/11 controls (p = 0.001). Seven of the 11 HSP patients were considered as having dementia.
CONCLUSION: This study indicates an active progression of cognitive deterioration and dementia in older patients with SPG4-ADHSP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14872021     DOI: 10.1212/01.wnl.0000108629.04434.05

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Gray and white matter alterations in hereditary spastic paraplegia type SPG4 and clinical correlations.

Authors:  Tobias Lindig; Benjamin Bender; Till-Karsten Hauser; Sarah Mang; Daniel Schweikardt; Uwe Klose; Kathrin N Karle; Rebecca Schüle; Ludger Schöls; Tim W Rattay
Journal:  J Neurol       Date:  2015-06-09       Impact factor: 4.849

2.  Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases.

Authors:  C Depienne; C Tallaksen; J Y Lephay; B Bricka; S Poea-Guyon; B Fontaine; P Labauge; A Brice; A Durr
Journal:  J Med Genet       Date:  2005-07-31       Impact factor: 6.318

3.  A novel mutation in KIF5A gene causing hereditary spastic paraplegia with axonal neuropathy.

Authors:  Olimpia Musumeci; Maria Teresa Bassi; Anna Mazzeo; Marina Grandis; Claudia Crimella; Andrea Martinuzzi; Antonio Toscano
Journal:  Neurol Sci       Date:  2010-11-24       Impact factor: 3.307

Review 4.  Hereditary spastic paraplegia.

Authors:  John K Fink
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

Review 5.  Cargos and genes: insights into vesicular transport from inherited human disease.

Authors:  Paul Gissen; Eamonn R Maher
Journal:  J Med Genet       Date:  2007-05-25       Impact factor: 6.318

6.  The neurological and ophthalmological manifestations of SPG4-related hereditary spastic paraplegia.

Authors:  Grant Guthrie; Gerald Pfeffer; Maura Bailie; Karen Bradshaw; Andrew C Browning; Rita Horvath; Patrick F Chinnery; Patrick Yu-Wai-Man
Journal:  J Neurol       Date:  2012-12-13       Impact factor: 4.849

7.  Cognitive Impairment Involving Social Cognition in SPG4 Hereditary Spastic Paraplegia.

Authors:  Ludivine Chamard; Sabrina Ferreira; Alexa Pijoff; Manon Silvestre; Eric Berger; Eloi Magnin
Journal:  Behav Neurol       Date:  2016-09-04       Impact factor: 3.342

Review 8.  Cognitive dysfunction in hereditary spastic paraplegias and other motor neuron disorders.

Authors:  Ingrid Faber; Lucas Melo T Branco; Marcondes Cavalvante França Júnior
Journal:  Dement Neuropsychol       Date:  2016 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.